SWKH

SWK Holdings Corp

Add to Watchlist

Advanced Chart

14.730

+0.055(0.375%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

14.730

Open

14.630

VWAP

14.68

Vol

10.85K

Mkt Cap

180.73M

Low

14.600

Amount

159.18K

EV/EBITDA(TTM)

6.97

Total Shares

12.47M

181.81M

EV/OCF(TTM)

6.76

P/S(TTM)

4.00

SWK Holdings Corporation is a life science focused specialty finance company partnering with small- and mid-sized commercial-stage healthcare companies. The Company provides non-dilutive financing to fuel the development and commercialization of lifesaving and life-enhancing medical technologies and products. The Company's solutions include structured debt, traditional royalty monetization, synthetic royalty transactions, and asset purchases typically ranging in size from $5.0 million to $25.0 million.

Get winning stock picks in minutes

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q2

FY2025Q3

FY2025Q4

0.180

-61.37%

0.260

-20.95%

0.260

-51.49%

Estimates Revision

The market is revising No Change the revenue expectations for SWK Holdings Corporation (SWKH) for FY2025, with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by 7.52%.

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Up

+7.52%

In Past 3 Month

2 Analyst Rating

15.41% Upside

Wall Street analysts forecast SWKH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SWKH is 17.00 USD with a low forecast of 16.00 USD and a high forecast of 18.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

0 Hold

0 Sell

Moderate Buy

15.41% Upside

Current: 14.730

Low

16.00

Averages

17.00

High

18.00

15.41% Upside

Current: 14.730

Low

16.00

Averages

17.00

High

18.00

Maxim

Buy

downgrade

$21 -> $18

2025-05-19

Reason

Maxim

Price Target

$21 -> $18

2025-05-19

downgrade

Buy

Reason

Maxim lowered the firm's price target on SWK Holdings to $18 from $21 and keeps a Buy rating on the shares. The tangible book value on the stock is down after the company's sale of its pharma royalty portfolio and the payout of its $4 per share special dividend, the analyst tells investors in a research note.

See All Ratings

Get winning stock picks in minutes

Valuation Metrics

The current forward P/E ratio for SWK Holdings Corp (SWKH.O) is 14.81, compared to its 5-year average forward P/E of 9.62. For a more detailed relative valuation and DCF analysis to assess SWK Holdings Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Overvalued

5Y Average PE

9.62

Current PE

14.81

Overvalued PE

12.30

Undervalued PE

6.95

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

4.41

Current PS

0.00

Overvalued PS

6.67

Undervalued PS

2.15